相关实验视频
Updated: Jun 10, 2025

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
1.9K
女作家在瘤学中的代表性:印度的观点
Vanita Noronha1, Manali Kolkur1, Chinmay Haridas2
1Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai 400012, India.
Ecancermedicalscience
|October 21, 2024
概括
印度瘤学期刊的女性作者数量正在增加,但仍然很低,特别是在编辑角色. 解决学术出版中的性别差异对于公平至关重要.
科学领域:
- 在瘤学瘤学.
- 学术出版学术出版公司
- 性别研究是性别研究.
背景情况:
- 尽管女性瘤学家的数量有所增加,但作者身份的性别差异仍然存在,特别是在高影响力期刊中.
- 本研究探讨了瘤学领域科学出版物中女性代表性不足的问题.
研究的目的:
- 在五年时间内,在选择的高影响力的印度瘤学期刊中调查作者身份的性别差异.
- 评估瘤学期刊出版物和编辑委员会性别差距的趋势.
主要方法:
- 分析来自六个具有影响力的印度瘤学期刊 (2017-2022) 的原始文章,评论和社论.
- 数据收集包括作者性别,第一/对应作者身份和期刊名称,通过网络搜索验证性别.
- 用描述性统计数据分析了女性作家的流行和趋势.
主要成果:
- 总共分析了2,235篇文章,其中30.4%的作者是女性.
- 随着时间的推移,女性作者的数量增加了 (33%至41%) 和相应的作者 (29.4%至36.4%),但差异仍然存在.
- 在编辑委员会中女性的代表性在3.5%至24.4%之间,这表明女性代表性严重不足.
结论:
- 在印度瘤学期刊中,女性作为作者和编辑委员会成员的代表性不成比例地低.
- 积极的措施是解决性别差异和促进学术瘤出版公平的必要条件.
更多相关视频
相关概念视频
Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

